Other Factors to Consider | GenomeWeb

The lack of a "revolution" following the Human Genome Project may indicate that researchers are not going about studying the link between genes and disease the right way, says Stephan Hall in this month's Scientific American. Proponents of the project foresaw personalized medicine as a possibility by 2010, but now Hall says "the scientific community finds itself sobered and divided." The dividing question is: do common genetic variants cause disease, or do rare genetic variants?

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.